✦ LIBER ✦

496 Efficacy and safety of 2 years adefovir dipivoxil (ADV) in chinese patients with HBeAg positive chronic hepatitis B (CHB)

✍ Scribed by M.D. Zeng; Y.M. Mao; G.B. Yao; H. Wang; J.L. Hou; Y.Z. Wang; J.S. Dixon; K.E. Barker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance surveillance of HBEAG— chroni

✍ S. Xiong; H. Yang; C.E. Westland; W.E. Delaney IV; D. Colledge; A. Bartholomeusz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Five years of treatment with adefovir di

✍ Zeng Minde; Mao Yimin; Yao Guangbi; Hou JinLin; Wang Hao; Ren Hong; Wang Yuming; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

Efficacy and safety of telbivudine plus

✍ Lu, Jia-Jie; Liu, Kai; Ma, Yuan-Ji; Wang, Juan; Chen, En-Qiang; Tang, Hong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Predicting HBEAG loss by HBV DNA early k

✍ A.U. Neumann; Y. Havlin; T. Ronen; M. Tsiang; M. Wulfsohn; C. Brosgart; J. Fry; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB

438 Continued safety and efficacy of add

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Efficacy of 96 weeks adefovir dipivoxil

✍ L. Zhuang; J. You; L. Kong; H. Lei; R.-D. Yang; X. Zhang; Q.-Q. Wang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 84 KB